Therapeutic potential of infrared-treated bee venom: enhanced multi-faceted bioactivity via compositional modulation

Husam Qanash , Aisha M. H. Al-Rajhi , Sulaiman A. Alsalamah , Abdulrahman S. Bazaid , Ali Alghubayshi , Safa H. Qahl , Amro Duhduh , Abadi M. Mashlawi , Mohamed M. Alawlaqi , Mashael Hakami

Bioresources and Bioprocessing ›› 2026, Vol. 13 ›› Issue (1) : 45

PDF
Bioresources and Bioprocessing ›› 2026, Vol. 13 ›› Issue (1) :45 DOI: 10.1186/s40643-026-01026-3
Research
research-article
Therapeutic potential of infrared-treated bee venom: enhanced multi-faceted bioactivity via compositional modulation
Author information +
History +
PDF

Abstract

Natural products are rich therapeutic sources, yet their translation into effective medicines remains challenging. Bee venom (BV) contains a diverse repertoire of bioactive molecules, but gentle, scalable methods to enhance its functionality are limited. This study, therefore, investigates a novel, solvent-free, post-extraction infrared (IR) conditioning step to fine-tune BV's composition and bioactivity. BV was irradiated (230 V, 50 Hz, 150 W) and compared to native extract using GC–MS and bioactivity assays. GC–MS revealed selective compositional tuning, with significant enrichment (p ≤ 0.05) of 4H-1-benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-3,5-dihydroxy-7-methoxy. IR-treated BV exhibited enhanced antimicrobial activity, with increased zones of inhibition for Staphylococcus aureus (15 ± 0.1 vs. 11 ± 0.4 mm), Bacillus subtilis (24 ± 0.2 vs. 22 ± 0.6 mm), Candida albicans (26 ± 0.1 vs. 22 ± 0.5 mm), Klebsiella pneumoniae (24 ± 0.4 vs. 15 ± 0.3 mm), and Salmonella typhi (27 ± 0.8 vs. 20 ± 0.7 mm). MICs decreased for S. aureusB. subtilis, and K. pneumoniae. The treated BV also showed stronger antibiofilm activity at 25% MBC concentrations for K. pneumoniae and S. typhi (p ≤ 0.05) and significantly reduced hemolysis at 25% MIC for S. aureus and B. subtilis (p ≤ 0.05). Antioxidant capacity increased (DPPH IC50: 16.47 ± 1.1 vs. 27.65 ± 0.8 µg/mL), as did anti-inflammatory activity (COX-2 IC50: 48.84 ± 0.2 vs. 50.99 ± 0.9 µg/mL; COX-1 IC50: 24.7 ± 0.2 vs. 41.74 ± 0.2 µg/mL). Cytotoxicity against PC-3 and SKOV-3 cells was maintained (IC50: 19.73 ± 0.9 and 19.76 ± 0.11 µg/mL, respectively, vs. native BV's 11.48 ± 0.3 and 17.46 ± 0.27 µg/mL). These findings establish brief IR irradiation as a practical, scalable post-processing strategy to selectively enhance the therapeutic potential of BV for biomedical applications.

Graphical abstract

Created in BioRender. Qanash, H. (2026) https://BioRender.com/6war4d0

[graphic not available: see fulltext]

Keywords

Bee venom / Infrared irradiation / Antimicrobial / Antioxidant / Antibiofilm / Antihemolytic / Anti-inflammatory / Anticancer

Cite this article

Download citation ▾
Husam Qanash, Aisha M. H. Al-Rajhi, Sulaiman A. Alsalamah, Abdulrahman S. Bazaid, Ali Alghubayshi, Safa H. Qahl, Amro Duhduh, Abadi M. Mashlawi, Mohamed M. Alawlaqi, Mashael Hakami. Therapeutic potential of infrared-treated bee venom: enhanced multi-faceted bioactivity via compositional modulation. Bioresources and Bioprocessing, 2026, 13(1): 45 DOI:10.1186/s40643-026-01026-3

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Abbaspour-Gilandeh Y, Kaveh M, Fatemi H, Khalife E, Witrowa-Rajchert D, Nowacka M. Effect of pretreatments on convective and infrared drying kinetics, energy consumption and quality of terebinth. Appl Sci, 2021, 11(16): 7672

[2]

Abd El-Wahed AA, Khalifa SA, Sheikh BY, Farag MA, Saeed A, Larik FA, El-Seedi HR. Bee venom composition: from chemistry to biological activity. Stud Natural Products Chem, 2019, 60: 459-484

[3]

Abdel Ghany TM, Ganash M, Alawlaqi MM, Al-Rajhi AMH. Antioxidant, antitumor, antimicrobial activities evaluation of Musa paradisiaca L. pseudostem exudate cultivated in Saudi Arabia. BioNanoScience, 2019, 9(1): 172-178

[4]

Aboud S A, Altemimi A B, A, R. S. A.-H., Yi-Chen L, & Cacciola F (2019) A comprehensive review on infrared heating applications in food processing. Molecules https://doi.org/10.3390/molecules24224125

[5]

Alawlaqi MM, Al-Rajhi AMH, Abdelghany TM, Ganash M, Moawad H. Evaluation of biomedical applications for linseed extract: antimicrobial, antioxidant, anti-diabetic, and anti-inflammatory activities in vitro. J Funct Biomater, 2023, 14(6): 300

[6]

Alecu A, Albu C, Badea G-I, Alionte A, Enache A-A, Radu G-L, Litescu S-C. Infrared laser-assisted extraction of bioactive compounds from Rosa canina L. Int J Mol Sci, 2025, 26(3): 992

[7]

Al-Rajhi AMH, Bakri MM, Qanash H, Alzahrani HY, Halawani H, Algaydi MA, Abdelghany TM. Antimicrobial, antidiabetic, antioxidant, and anticoagulant activities of Cupressus sempervirens in vitro and in silico. Molecules, 2023,

[8]

Al-Rajhi AMH, Qanash H, Almashjary MN, Hazzazi MS, Felemban HR, Abdelghany TM. Anti-Helicobacter pylori, antioxidant, antidiabetic, and anti-Alzheimer's activities of laurel leaf extract treated by moist heat and molecular docking of its flavonoid constituent, naringenin, against acetylcholinesterase and butyrylcholinesterase. Life, 2023,

[9]

Al-Rajhi AMH, Abdelghany TM, Selim S, Almuhayawi MS, Alruhaili MH, Alharbi MT, Al Jaouni SK. Phytochemical characterization of peanut oil and its ozonized form to explore biological activities in vitro. AMB Express, 2025, 15(1): 76

[10]

Alsalamah SA, Alghonaim MI, Mohammad AM, Khalel AF, Alqahtani FS, Abdelghany TM. Ozone-modified properties of pumpkin seed oil as anti-H. pylori, anticancer, anti-diabetic and anti-obesity agent. Sci Rep, 2025, 15(1): 25959

[11]

Awad EH, Arafa W, Ali HR, Barakat OS, Ahmed MN. Unveiling the anti-biofilm potential of bee venom against multi-drug resistant human pathogenic bacteria and fungi: perspectives into the efficacy and possible mechanisms. Microb Pathog, 2025, 200: 107358

[12]

Azad MOK, Piao JP, Park CH, Cho DH. Far infrared irradiation enhances nutraceutical compounds and antioxidant properties in Angelica gigas Nakai powder. Antioxidants, 2018,

[13]

Bava R, Castagna F, Musella V, Lupia C, Palma E, Britti D. Therapeutic use of bee venom and potential applications in veterinary medicine. Vet Sci, 2023,

[14]

Bishayee A, Penn A, Bhandari N, Petrovich R, DeLiberto LK, Burcher JT, Barbalho SM, Nagini S. Dietary plants for oral cancer prevention and therapy: a review of preclinical and clinical studies. Phytother Res, 2024, 38(11): 5225-5263

[15]

Campos MG, Frigerio C, Bobiş O, Urcan AC, Gomes NGM. Infrared irradiation drying impact on bee pollen: case study on the phenolic composition of Eucalyptus globulus Labill and Salix atrocinerea Brot. pollens. Processes, 2021, 9(5): 890

[16]

Carpena M, Nuñez-Estevez B, Soria-Lopez A, Simal-Gandara J. Bee venom: an updating review of its bioactive molecules and its health applications. Nutrients, 2020,

[17]

Chahal S, Rani P, Kiran, Sindhu J, Joshi G, Ganesan A, Kalyaanamoorthy S, Mayank, Kumar P, Singh R, & Negi A (2023). Design and development of COX-II inhibitors: current scenario and future perspective. ACS Omega, 8(20), 17446–17498. https://doi.org/10.1021/acsomega.3c00692

[18]

Choudhary P, Tushir S, Bala M, Sharma S, Sangha MK, Rani H, Yewle NR, Kumar P, Singla D, Chandran D, Kumar M, Mekhemar M. Exploring the potential of bee-derived antioxidants for maintaining oral hygiene and dental health: a comprehensive review. Antioxidants, 2023,

[19]

Chunarkar-Patil P, Kaleem M, Mishra R, Ray S, Ahmad A, Verma D, Bhayye S, Dubey R, Singh HN, Kumar S. Anticancer drug discovery based on natural products: from computational approaches to clinical studies. Biomedicines, 2024,

[20]

Dodia H, Ojha S, Chatterjee P, Beuria TK. 10058-F4 mediated inhibition of the biofilm formation in multidrug-resistant Staphylococcus aureus. Biofilm, 2025, 10: 100307

[21]

El Mehdi I, Falcão SI, Boujraf S, Mustapha H, Campos MG, Vilas-Boas M. Analytical methods for honeybee venom characterization. J Adv Pharm Technol Res, 2022, 13(3): 154-160

[22]

El-Bilawy EH, Mamdouh I, Behiry S, Teiba II. Evaluating the antibacterial efficacy of bee venom against multidrug-resistant pathogenic bacteria: Escherichia coli, Salmonella typhimurium, and Enterococcus faecalis. World J Microbiol Biotechnol, 2025, 41(2): 40

[23]

Elkomy AE, Sadaka TA, Hassan SS, Shawky O, El-Speiy ME, El-Beshkar M, Wadaan MAM, El-Tahan HM, Cho S, Kim IH, El-Tahan HM. Improving productive performance, immunity, and health status of growing rabbits by using honey bee venom (Apis mellifera). Front Vet Sci, 2023, 10: 1234675

[24]

El-Seedi H, Abd El-Wahed A, Yosri N, Musharraf SG, Chen L, Moustafa M, Zou X, Al-Mousawi S, Guo Z, Khatib A, Khalifa S. Antimicrobial properties of Apis mellifera's bee venom. Toxins (Basel), 2020,

[25]

El-Seedi HR, Eid N, Abd El-Wahed AA, Rateb ME, Afifi HS, Algethami AF, Zhao C, Al Naggar Y, Alsharif SM, Tahir HE, Xu B, Wang K, Khalifa SAM. Honey bee products: preclinical and clinical studies of their anti-inflammatory and immunomodulatory properties. Front Nutr, 2021, 8: 761267

[26]

Erkoc P, von Reumont BM, Lüddecke T, Henke M, Ulshöfer T, Vilcinskas A, Fürst R, Schiffmann S. The pharmacological potential of novel melittin variants from the honeybee and solitary bees against inflammation and cancer. Toxins (Basel), 2022,

[27]

Fastl C, De Carvalho Ferreira HC, Babo Martins S, Sucena Afonso J, di Bari C, Venkateswaran N, Pires SM, Mughini-Gras L, Huntington B, Rushton J, Pigott D, Devleesschauwer B. Animal sources of antimicrobial-resistant bacterial infections in humans: a systematic review. Epidemiol Infect, 2023, 151: e143

[28]

Gajski G, Leonova E, Sjakste N. Bee venom: composition and anticancer properties. Toxins (Basel), 2024,

[29]

Gonzalez-Pastor R, Carrera-Pacheco SE, Zúñiga-Miranda J, Rodríguez-Pólit C, Mayorga-Ramos A, Guamán LP, Barba-Ostria C. Current landscape of methods to evaluate antimicrobial activity of natural extracts. Molecules, 2023, 28(3): 1068

[30]

Hammoud M, Chokr A, Rajha HN, Safi C, Walsem M, Broek LAMvd, Debs E, Maroun RG, Louka N, Rammal H. Intensification of polyphenols extraction from Eryngium creticum leaves using Ired-Irrad® and evaluation of antibiofilm and antibacterial activities. Plants, 2022, 11(19): 2458

[31]

Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov, 2022, 12(1): 31-46

[32]

Isidorov V, Zalewski A, Zambrowski G, Swiecicka I. Chemical composition and antimicrobial properties of honey bee venom. Molecules, 2023, 28(10): 4135

[33]

Ketha A, Vedula GS, Sastry AVS. In vitro antioxidant, anti-inflammatory, and anticancer activities of methanolic extract and its metabolites of whole plant Cardiospermum canescens Wall. Future J Pharm Sci, 2020, 6(1): 11

[34]

Kocyigit A, Guler EM, Kaleli S. Anti-inflammatory and antioxidative properties of honey bee venom on Freund's Complete Adjuvant-induced arthritis model in rats. Toxicon, 2019, 161: 4-11

[35]

Kumar KBV, Varadaraju KR, Shivaramu PD, Kumar CMH, Prakruthi HR, Shekara BMC, Shreevatsa B, Wani TA, Prakasha KC, Kollur SP, Shivamallu C. Bactericidal, anti-hemolytic, and anticancerous activities of phytofabricated silver nanoparticles of glycine max seeds. Front Chem, 2024, 12: 1427797

[36]

Lin YK, Yang SC, Hsu CY, Sung JT, Fang JY. The antibiofilm nanosystems for improved infection inhibition of microbes in skin. Molecules, 2021,

[37]

Luzala MM, Muanga CK, Kyana J, Safari JB, Zola EN, Mbusa GV, Nuapia YB, Liesse JI, Nkanga CI, Krause RWM, Balčiūnaitienė A, Memvanga PB. A critical review of the antimicrobial and antibiofilm activities of green-synthesized plant-based metallic nanoparticles. Nanomaterials (Basel), 2022,

[38]

Maitip J, Mookhploy W, Khorndork S, Chantawannakul P. Comparative study of antimicrobial properties of bee venom extracts and melittins of honey bees. Antibiotics (Basel), 2021,

[39]

Małek A, Strzemski M, Kurzepa J, Kurzepa J. Can bee venom be used as anticancer agent in modern medicine?. Cancers (Basel), 2023,

[40]

Montaser M, Sayed AM, Bishr MM, Zidan EW, Zaki MA, Hassan HM, Mohammed R, Hifnawy MS. GC-MS analysis of honeybee products derived from medicinal plants. Beni-Suef Univ J Basic Appl Sci, 2023, 12(1): 63

[41]

Muteeb G, Rehman MT, Shahwan M, Aatif M. Origin of antibiotics and antibiotic resistance, and their impacts on drug development: a narrative review. Pharmaceuticals (Basel), 2023,

[42]

Nortjie E, Basitere M, Moyo D, Nyamukamba P. Assessing the efficiency of antimicrobial plant extracts from Artemisia afra and Eucalyptus globulus as coatings for textiles. Plants, 2024, 13(4): 514

[43]

Pérez-Delgado O, Espinoza-Culupú AO, López-López E. Antimicrobial activity of Apis mellifera bee venom collected in Northern Peru. Antibiotics, 2023,

[44]

Prathap R, Kirubha S, Rajan AT, Manoharan S, Elumalai K. The increasing prevalence of cancer in the elderly: an investigation of epidemiological trends. Aging Med (Milton), 2024, 7(4): 516-527

[45]

Pucca MB, Cerni FA, Oliveira IS, Jenkins TP, Argemí L, Sørensen CV, Ahmadi S, Barbosa JE, Laustsen AH. Bee updated: current knowledge on bee venom and bee envenoming therapy. Front Immunol, 2019, 10: 2090

[46]

Qanash H, Bazaid AS, Alharbi SF, Binsaleh NK, Barnawi H, Alharbi B, Alsolami A, Almashjary MN. Therapeutic effects of nanocoating of apitoxin (bee venom) and polyvinyl alcohol supplemented with Zinc Oxide nanoparticles. Pharmaceutics, 2025, 17(2): 172

[47]

Qanash H, Bazaid AS, Binsaleh NK, Alshammari AS, Eltayeb R. Therapeutic potential of Plantago ovata bioactive extracts obtained by supercritical fluid extraction as influenced by temperature on anti-obesity, anticancer, and antimicrobial activities. Plants, 2025, 14(12): 1813

[48]

Rabea EY, Mahmoud ED, Mohamed NK, Ansary ER, Alrouby MR, Shehata RR, Mokhtar YY, Arullampalam P, Hegazy AM, Al-Sabi A, Abd El-Aziz TM. Potential of venom-derived compounds for the development of new antimicrobial agents. Toxins, 2025, 17(5): 238

[49]

Rady I, Siddiqui IA, Rady M, Mukhtar H. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett, 2017, 402: 16-31

[50]

Rahman MT, Sobur MA, Islam MS, Ievy S, Hossain MJ, El Zowalaty ME, Rahman AT, Ashour HM. Zoonotic diseases: etiology, impact, and control. Microorganisms, 2020,

[51]

Rizvi SAA, Einstein GP, Tulp OL, Sainvil F, Branly R. Introduction to traditional medicine and their role in prevention and treatment of emerging and re-emerging diseases. Biomolecules, 2022,

[52]

Rossignol G, Merieau A, Guerillon J, Veron W, Lesouhaitier O, Feuilloley MGJ, Orange N. Involvement of a phospholipase C in the hemolytic activity of a clinical strain of Pseudomonas fluorescens. BMC Microbiol, 2008, 8(1): 189

[53]

Saad B. Immunomodulatory and anti-inflammatory properties of honey and bee products. Immuno, 2025, 5(2): 19

[54]

Sabbaghi H, & Nguyen P N (2025) Infrared drying in food technology: principles and practical insights. In J. Chandrapala (Ed.), Novel Drying Technologies in Food Science. IntechOpen. https://doi.org/10.5772/intechopen.1009292

[55]

Selim S, Abdelghany TM, Almuhayawi MS, Nagshabandi MK, Tarabulsi MK, Elamir MYM, Alharbi AA, Al Jaouni SK. Biosynthesis and activity of Zn-MnO nanocomposite in vitro with molecular docking studies against multidrug resistance bacteria and inflammatory activators. Sci Rep, 2025, 15(1): 2032

[56]

Seyam H, Metwally AAA, El-Deeb AH, El-Mohandes S, Badr MS, Abd-El-Samie EM. Effect of honeybee venom and Egyptian propolis on the honeybee (Apis mellifera L.) health in vivo. Egypt J Biol Pest Control, 2022, 32(1): 78

[57]

Shi P, Xie S, Yang J, Zhang Y, Han S, Su S, Yao H. Pharmacological effects and mechanisms of bee venom and its main components: recent progress and perspective. Front Pharmacol, 2022, 13: 1001553

[58]

Stela M, Cichon N, Spławska A, Szyposzynska M, Bijak M. Therapeutic potential and mechanisms of bee venom therapy: a comprehensive review of apitoxin applications and safety enhancement strategies. Pharmaceuticals (Basel), 2024,

[59]

Togrul H. Simple modeling of infrared drying of fresh apple slices. J Food Eng, 2005, 71: 311-323

[60]

Tran KB, Lang JJ, Compton K, Xu R, Acheson AR, Henrikson HJ, Banach M. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 2022, 400(10352): 563-591

[61]

Ullah A, Aldakheel FM, Anjum SI, Raza G, Khan SA, Tlak Gajger I. Pharmacological properties and therapeutic potential of honey bee venom. Saudi Pharm J, 2023, 31(1): 96-109

[62]

Wehbe R, Frangieh J, Rima M, El Obeid D, Sabatier JM, Fajloun Z. Bee venom: overview of main compounds and bioactivities for therapeutic interests. Molecules, 2019,

[63]

Yacoub T, Rima M, Karam M, Fajloun J. Antimicrobials from venomous animals: an overview. Molecules, 2020,

[64]

Zhu J, Li S, Li X, Wang L, Du L, Qiu Y. Impact of population ageing on cancer-related disability-adjusted life years: a global decomposition analysis. J Glob Health, 2024, 14: 04144

Funding

Deanship of Scientific Research, Princess Nourah Bint Abdulrahman University(PNURSP2026R217)

RIGHTS & PERMISSIONS

The Author(s)

PDF

0

Accesses

0

Citation

Detail

Sections
Recommended

/